I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
The combination of anti-KIR monoclonal antibodies with anti..:
He, Yayi
;
Liu, Sangtian
;
Mattei, Jane
...
Drug Design, Development and Therapy. 12 (2018) - p. 981-986 , 2018
Link:
https://doi.org/10.2147/dddt.s163304
RT Journal T1 <Title>The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC</Title> UL https://suche.suub.uni-bremen.de/peid=cr-10.2147_dddt.s163304&Exemplar=1&LAN=DE A1 He, Yayi A1 Liu, Sangtian A1 Mattei, Jane A1 Bunn Jr, Paul A1 Zhou, Caicun A1 Chan, Daniel PB Informa UK Limited YR 2018 SN 1177-8881 JF Drug Design, Development and Therapy VO 12 SP 981 OP 986 LK http://dx.doi.org/https://doi.org/10.2147/dddt.s163304 DO https://doi.org/10.2147/dddt.s163304 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
